Dr. Alan Sandler from the Oregon Health & Science University Discusses Immunotherapies for Lung Cancer
Alan Sandler, MD
Advertisement
Articles by Alan Sandler, MD
Dr. Alan Sandler, from the Oregon Health & Science University, Discusses the Tivantinib Mechanism of Action
Advertisement
Latest Updated Articles
Dr. Sandler Discusses the Tivantinib Mechanism of ActionJune 25th 2012
Dr. Sandler on Immunotherapies to Treat Lung CancerAugust 2nd 2012
Advertisement
Advertisement
Trending on OncLive
1
Mo-Rez Responses Span B7-H4 Expression Levels in Platinum-Resistant Ovarian Cancer in BEHOLD-1 Biomarker Analysis
2
Genomic Testing, Toxicity, and Sequencing Shape Treatment Decisions in Advanced Prostate Cancer
3
FDA Approves Pimicotinib for Symptomatic TGCT
4
Dr Natsuhara on Treatment Advances and Research Considerations in TNBC
5